EndoQuest Receives FDA Approval to Initiate Final Stage of PARADIGM Trial
U.S. FDA grants approval to complete enrollment in EndoQuest’s ongoing PARADIGM Trial following the clinical study’s favorable interim safety review EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic...
